Richard Simmons
Pulmonary Disease · Lagrange, GANPI 1417942293
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.2% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $918 and has fallen 79.1% since, to $192 in 2023. That places this record below the midpoint for pulmonary disease clinicians in GA, where the typical reported total is $3,789.
Across 114 payments — averaging $17.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$444
- GSK$441
- Regeneron Healthcare Solutions, Inc.$182
- Sanofi$139
- Boehringer Ingelheim$134
- Mallinckrodt Hospital Products Inc.$100
- plus $562 from 16 others
What the payments were for
- Food & beverage$1,88694%
- Education$1166%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 23 | $444 |
| GSK | 31 | $441 |
| Regeneron Healthcare Solutions, Inc. | 9 | $182 |
| Sanofi | 6 | $139 |
| Boehringer Ingelheim | 9 | $134 |
| Mallinckrodt Hospital Products Inc. | 1 | $100 |
| Mylan Specialty L.p. | 4 | $64 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $60 |
| Johnson & Johnson | 4 | $58 |
| Shire North American Group Inc | 3 | $52 |
| Advanced Respiratory, Inc | 2 | $46 |
| United Therapeutics Corporation | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $43 |
| Inogen, Inc. | 2 | $43 |
| Insmed, Inc. | 3 | $42 |
| Merck | 1 | $19 |
| Mallinckrodt Enterprises LLC | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Resmed Corp | 1 | $16 |
| Intercept Pharmaceuticals, Inc. | 1 | $15 |
| Evoke Pharma, Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
How this compares
$2,002 in reported general payments places this provider in the 35th percentile of 365 pulmonary disease providers in Georgia.
Other pulmonary disease in Lagrange
- Lawrence McDermottSavannah$963K
- Vivek SambharaGainesville$417K
- Chad MillerAustell$382K
- Nehal BhattAthens$371K
- Maria MascoloRincon$358K
- Colin SwensonAtlanta$255K
- David MillerDecatur$206K
- Michael MullinsSavannah$132K
- Hitendra PatelMarietta$104K
- Eric FlenaughAtlanta$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.